2/25
08:14 am
ipsc
Century Therapeutics to Participate in Upcoming Investor Conferences in March [Yahoo! Finance]
Low
Report
Century Therapeutics to Participate in Upcoming Investor Conferences in March [Yahoo! Finance]
2/25
08:00 am
ipsc
Century Therapeutics (IPSC) is now covered by TD Cowen. They set a "buy" rating on the stock.
Medium
Report
Century Therapeutics (IPSC) is now covered by TD Cowen. They set a "buy" rating on the stock.
2/25
08:00 am
ipsc
Century Therapeutics to Participate in Upcoming Investor Conferences in March
Medium
Report
Century Therapeutics to Participate in Upcoming Investor Conferences in March
2/9
11:21 am
ipsc
Century Therapeutics: A Very Promising Contender In The Type I Diabetes Mellitus Functional Cure Race [Seeking Alpha]
Medium
Report
Century Therapeutics: A Very Promising Contender In The Type I Diabetes Mellitus Functional Cure Race [Seeking Alpha]
2/1
01:30 am
ipsc
Century Therapeutics (NASDAQ:IPSC) was downgraded by analysts at
Wall St
Medium
Report
Century Therapeutics (NASDAQ:IPSC) was downgraded by analysts at
Wall St
1/30
03:28 pm
ipsc
Piper Sandler Highlights Century Therapeutics (IPSC) Cash Runway Through 2029, Upcoming IND Submission [Yahoo! Finance]
Low
Report
Piper Sandler Highlights Century Therapeutics (IPSC) Cash Runway Through 2029, Upcoming IND Submission [Yahoo! Finance]
1/24
03:01 am
ipsc
Century Therapeutics (NASDAQ:IPSC) was upgraded by analysts at
Wall Stre
Medium
Report
Century Therapeutics (NASDAQ:IPSC) was upgraded by analysts at
Wall Stre
1/22
01:42 pm
ipsc
Century Therapeutics (IPSC) Upgraded to Strong Buy: Here's What You Should Know [Yahoo! Finance]
Low
Report
Century Therapeutics (IPSC) Upgraded to Strong Buy: Here's What You Should Know [Yahoo! Finance]
1/20
07:17 am
ipsc
Century Therapeutics (NASDAQ:IPSC) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
High
Report
Century Therapeutics (NASDAQ:IPSC) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
1/8
08:17 am
ipsc
Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing to Support Lead Program, CNTY-813, a Potentially Curative Therapy for Type 1 Diabetes [Yahoo! Finance]
Medium
Report
Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing to Support Lead Program, CNTY-813, a Potentially Curative Therapy for Type 1 Diabetes [Yahoo! Finance]
1/8
08:00 am
ipsc
Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing to Support Lead Program, CNTY-813, a Potentially Curative Therapy for Type 1 Diabetes
High
Report
Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing to Support Lead Program, CNTY-813, a Potentially Curative Therapy for Type 1 Diabetes
1/8
06:15 am
ipsc
Century Therapeutics (NASDAQ:IPSC) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
High
Report
Century Therapeutics (NASDAQ:IPSC) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
12/9
08:00 am
ipsc
Century Therapeutics Appoints Accomplished Biotechnology Leaders Dr. Han Lee and Dr. Martin Murphy to Board of Directors
Medium
Report
Century Therapeutics Appoints Accomplished Biotechnology Leaders Dr. Han Lee and Dr. Martin Murphy to Board of Directors